Bayer Wins Approval for $7.25 Billion Roundup Settlement
A Missouri judge has approved Bayer’s settlement of US lawsuits alleging that its Roundup weedkiller causes cancer. Payments to eligible participants will range from $10,000 to $165,000, with the company funding the agreement over as many as 21 years.

Bayer has won approval for a $7.25 billion settlement of US lawsuits alleging that its Roundup weedkiller causes cancer. A Missouri judge approved the agreement, which covers eligible users already diagnosed with non-Hodgkin lymphoma and those who develop it in the future.
The German company denies that Roundup causes cancer. It had faced approximately 65,000 claims in US state and federal courts from people who said they developed cancer after using the weedkiller at home or at work.
Payments and objections
Individual settlement payments range from $10,000 to $165,000. Amounts depend on how often participants used Roundup, when they were diagnosed and the severity of their illness.
Bayer will make annual payments into a fund for up to 21 years, providing as much as $7.25 billion. The agreement announced in February aimed to resolve nearly all current and future Roundup claims in the US.
Judge Timothy Boyer, of a state court in St. Louis, found the settlement “fair, reasonable, and adequate.” He overruled objections that individual payments would be too low because some claimants who settled earlier received more.
Boyer said further delay could force victims, including people with terminal cancer, to wait “an indeterminate number of years” for payment.
Some cases will continue. Bayer has said about 200 lawsuits excluded from the settlement were still being litigated in federal court.
Supreme Court ruling narrowed claims
The approval followed a US Supreme Court decision in June that overturned a $1.25 million jury award to Missouri resident John Durnell. He blamed years of exposure to Roundup’s active ingredient, glyphosate, for his non-Hodgkin lymphoma.
The court ruled 7-2 that a federal law regulating pesticides barred claims brought under state law over a failure to warn. Lawyer Christopher Seeger, who represents many plaintiffs, said the decision narrowed victims’ ability to pursue claims in court.
Bayer settled much of the Roundup litigation for $10.9 billion in 2020. It did not win court approval for a separate $1.25 billion settlement intended to resolve future claims.
Monsanto developed Roundup in the 1970s. Bayer bought Monsanto for $63 billion in 2018.
In 2015, the International Agency for Research on Cancer, a World Health Organization unit, identified glyphosate as a probable human carcinogen. Bayer and regulators including the US Environmental Protection Agency have disputed that finding.
Bayer has maintained that Roundup and glyphosate are safe, and that decades of studies showed glyphosate did not cause cancer.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →- 1Stock Market Today: Dow Slides 1.34% and VIX Jumps 15% at Midday

- 2Joachim Klement to Sell Stocks After S&P 500 Signal

- 3Stock Market Today: Nasdaq, S&P 500 Futures Slide as AI Selloff Deepens

- 4Kenneth Walker’s Groin Injury Puts Cardinals Game in Doubt

- 5Pat Cummins Faces Captaincy Doubts From Mitchell Johnson

Markets · FintechHow to Calculate Compound Interest: Formula, Examples and the Rule of 72
Lifestyle · Food & HealthNormal Blood Pressure Chart by Age: Healthy Ranges Explained
Lifestyle · Food & HealthWhat Is Raynaud’s Syndrome? Why Fingers Turn White in the Cold
Lifestyle · Food & Health4 Ways Walking After Meals Helps Your Body, Doctors Say















